JPRN-UMIN000021327已完成未知
The effect of canagliflozin on body fat volume - Canagliflozin for body fat
Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School0 个研究点目标入组 15 人开始时间: 2016年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Hypersensitivity to canagliflozin, Complicated with sever ketoacidosis, diabetic coma, Type 1 diabetes Complicated with severe infection, sever trauma
研究者
相似试验
尚未招募
不适用
The effect of tofogliflozin on body fat volumeType 2 diabetesJPRN-UMIN000036013Tokushima University Graduate School15
已完成
不适用
Effects of canagliflozin on the hepatic steatosis, adipose tissue and skeletal muscle in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease / non-alcoholic steatohepatitisJPRN-UMIN000018814Yokohama City University Graduate School of Medicine20
已完成
不适用
The effect of ipragliflozin on ectopic fat accumulation in non-obese type 2 diabetic patients with increased visceral fatType 2 diabetesJPRN-UMIN000019071Tokyo Medical and Dental University20
已完成
不适用
The impact of Dapagliflozin on epicardial fat volumeType 2 DiabetesJPRN-UMIN000035660Tachikawa general hospital40
尚未招募
不适用
Canagliflozin in non diabetic proteinuric diseaseCTRI/2020/09/027679COMMAND HOSPITAL AIR FORCE BANGALORE